Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04838899
What this trial is testing

Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Who this might be right for
OligoprogressiveCastration-Resistant Prostate Cancer
Sunnybrook Health Sciences Centre 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06691984
What this trial is testing

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 707
Testing effectiveness (Phase 2)Study completedNCT01756638
What this trial is testing

Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05340374
What this trial is testing

Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancermCRPC
Peter MacCallum Cancer Centre, Australia 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05828082
What this trial is testing

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Castration-Resistant Prostate CarcinomaRefractory Prostate Carcinoma+1 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Looking for participantsNCT07414940
What this trial is testing

ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Prostate CancerProstate Cancer
University College, London 60
Testing effectiveness (Phase 2)Study completedNCT03103724
What this trial is testing

A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.

Who this might be right for
Carcinoma Prostate
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 68
Testing effectiveness (Phase 2)Study completedNCT03338790
What this trial is testing

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 292
Testing effectiveness (Phase 2)Ended earlyNCT03869762
What this trial is testing

Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.

Who this might be right for
Castration-resistant Prostate CancerMetastatic CancerBone Metastases
Cancer Trials Ireland 7
Testing effectiveness (Phase 2)Looking for participantsNCT05393791
What this trial is testing

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Leiden University Medical Center 168
Early research (Phase 1)Study completedNCT01414296
What this trial is testing

Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT04028388
What this trial is testing

ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Modra Pharmaceuticals 135
Post-approval studies (Phase 4)Study completedNCT01995513
What this trial is testing

Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Pfizer 509
Testing effectiveness (Phase 2)Study completedNCT03418324
What this trial is testing

Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

Who this might be right for
Prostate Cancer
Cedars-Sinai Medical Center 11
Early research (Phase 1)WithdrawnNCT04879589
What this trial is testing

Phase 1 Study of ATRS-2002 in Healthy Male Adults

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Syneos Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT03431350
What this trial is testing

Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC 136
Testing effectiveness (Phase 2)Looking for participantsNCT05766371
What this trial is testing

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Cancer+1 more
University of California, San Francisco 48
Early research (Phase 1)Ended earlyNCT06287463
What this trial is testing

Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

Who this might be right for
Advanced Solid TumorRAF MutationRAS Mutation+7 more
Deciphera Pharmaceuticals, LLC 29
Not applicableApproved For MarketingNCT05401214
What this trial is testing

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)UnknownNCT02484339
What this trial is testing

Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)

Who this might be right for
Prostate Carcinoma
University Hospital Freiburg 274
Next Page